While the association between IL13Rα2 and proliferative signature genes is intriguing, this was difficult to assess further because of the limited set of five genes defining the proliferative tumor subtype, and for technical reasons three could not be evaluated in all of the eight studies queried for this analysis (see Methods). The gene discussed is IL13RA2; the disease is neoplasm.